IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
4
Neutral
7
Bullish
3
Bearish
22
Neutral
11
Bullish
13
Bearish
18
Neutral
4
Bullish
10
Healthcare Services
Healthcare Service Provider
88 Cr
Low Risk
16.7
59.7
—
1.5
100.00
45.00
Sales CAGR
Profit CAGR
ROE
ROCE
Modern Diagnostic & Research Centre Ltd (MDRCL) is currently trading at 58.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Modern Diagnostic & Research Centre Ltd operates in the its sector sector. Review the About Company section on this page to understand its business model, revenue streams, and key products or services.
Over the past 52 weeks, Modern Diagnostic & Research Centre Ltd has traded between a low of ₹45.00 and a high of ₹100.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Modern Diagnostic & Research Centre Ltd has a market capitalization of approximately 87.58. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Modern Diagnostic & Research Centre Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 16.68 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 87.58 Cr, Modern Diagnostic & Research Centre Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Modern Diagnostic & Research Centre Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Modern Diagnostic & Research Centre Ltd is 16.68. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
198.60 | 138 Cr | 64.04 | 5.41 | 0.00 | 5.87 | 8.80 | 3.00 | ||
69.00 | 135 Cr | 26.85 | 2.57 | 0.00 | 9.53 | 9.10 | 0.00 | ||
129.15 | 133 Cr | 55.39 | 18.37 | 0.00 | 16.62 | 13.17 | 13.75 | ||
67.35 | 117 Cr | 6.88 | 1.01 | 0.00 | 16.61 | 20.64 | 11.10 | ||
83.00 | 104 Cr | 21.25 | 2.09 | 0.00 | 9.83 | 13.44 | 8.08 | ||
58.00 | 88 Cr | 16.68 | 1.50 | 0.00 | 8.97 | 8.79 | 4.43 | ||
104.45 | 35 Cr | 15.98 | 0.90 | 3.35 | 5.59 | 6.39 | 5.20 | ||
| Median: 7 Co. | — | 83.00 | 117 Cr | 21.25 | 2.09 | 0.00 | 9.53 | 9.10 | 5.20 |
